Fairfax Station, VA, United States of America

George A Robertson


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: George A. Robertson: Innovator in Immunogenic Compositions

Introduction

George A. Robertson is a notable inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on whole-cell vaccines. His research has paved the way for advancements in vaccine development, which are crucial for public health.

Latest Patents

Robertson holds a patent for a selectively disrupted whole-cell vaccine. This invention provides immunogenic compositions and methods for producing an immunogenic composition with multiple immunity-inducing fractions of killed, whole cells. By selectively disrupting a whole cell bacterial preparation, the invention ensures that both a soluble fraction, which induces a primarily antibody response, and a cellular fraction, which induces a primarily antibody-independent response, remain in the immunogenic composition. This innovative approach enhances the effectiveness of vaccines.

Career Highlights

Throughout his career, Robertson has worked with several organizations that focus on medical advancements. Notably, he has been associated with Children's Medical Center Corporation and Path Vaccine Solutions. His work in these institutions has contributed to the development of effective medical solutions and has had a lasting impact on the field of immunology.

Collaborations

Robertson has collaborated with esteemed professionals in his field, including Richard Malley and Porter Anderson. These collaborations have fostered a productive environment for innovation and have led to significant advancements in vaccine research.

Conclusion

George A. Robertson's contributions to immunogenic compositions and whole-cell vaccines highlight his role as an influential inventor in the field of immunology. His innovative approaches and collaborations have the potential to improve vaccine efficacy and public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…